癌症孕妇的程序性流产、提供者引发的早产和存活率:基于人群的队列研究。

IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY
Amy Metcalfe, Zoe F Cairncross, Joel G Ray, Lorraine Shack, Gregg Nelson, Christine M Friedenreich, Khokan Sikdar, Sarka Lisonkova, Carly A McMorris, Parveen Bhatti, Deshayne B Fell
{"title":"癌症孕妇的程序性流产、提供者引发的早产和存活率:基于人群的队列研究。","authors":"Amy Metcalfe, Zoe F Cairncross, Joel G Ray, Lorraine Shack, Gregg Nelson, Christine M Friedenreich, Khokan Sikdar, Sarka Lisonkova, Carly A McMorris, Parveen Bhatti, Deshayne B Fell","doi":"10.1111/1471-0528.17937","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To assess whether procedural-induced abortion or provider-initiated preterm delivery are associated with improved survival in pregnant people with cancer.</p><p><strong>Design: </strong>Retrospective population-based cohort study.</p><p><strong>Setting: </strong>Provinces of Alberta and Ontario, Canada, 2003-2016.</p><p><strong>Population: </strong>Females aged 18-50 years diagnosed with cancer at <20 weeks' (for the assessment of procedural-induced abortion) or <37 weeks' gestation (for the assessment of provider-initiated delivery).</p><p><strong>Methods: </strong>Cox proportional hazard models assessed all-cause mortality in relation to procedural-induced abortion and provider-initiated preterm delivery, adjusting for cancer site, stage at diagnosis and age. Meta-analysis pooled the results across both provinces.</p><p><strong>Main outcome measures: </strong>All cause mortality.</p><p><strong>Results: </strong>There were 512 pregnant people diagnosed with cancer at <20 weeks' gestation and 782 diagnosed with cancer at <37 weeks' gestation. Neither procedural-induced abortion (adjusted hazard ratio [aHR] = 1.39, 95% CI: 0.32-6.17) nor provider-initiated preterm delivery (aHR = 1.17, 95% CI: 0.76-1.81) were associated with improved survival following adjustment for age, stage at diagnosis and cancer site.</p><p><strong>Conclusions: </strong>Neither procedural-induced abortion nor provider-initiated preterm birth was associated with improved survival in pregnant people diagnosed with cancer; however, these obstetric interventions are highly personal decisions best decided by the pregnant person in consultation with their care providers.</p>","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":null,"pages":null},"PeriodicalIF":4.7000,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Procedural abortion, provider-initiated preterm delivery and survival in pregnant people with cancer: A population-based cohort study.\",\"authors\":\"Amy Metcalfe, Zoe F Cairncross, Joel G Ray, Lorraine Shack, Gregg Nelson, Christine M Friedenreich, Khokan Sikdar, Sarka Lisonkova, Carly A McMorris, Parveen Bhatti, Deshayne B Fell\",\"doi\":\"10.1111/1471-0528.17937\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To assess whether procedural-induced abortion or provider-initiated preterm delivery are associated with improved survival in pregnant people with cancer.</p><p><strong>Design: </strong>Retrospective population-based cohort study.</p><p><strong>Setting: </strong>Provinces of Alberta and Ontario, Canada, 2003-2016.</p><p><strong>Population: </strong>Females aged 18-50 years diagnosed with cancer at <20 weeks' (for the assessment of procedural-induced abortion) or <37 weeks' gestation (for the assessment of provider-initiated delivery).</p><p><strong>Methods: </strong>Cox proportional hazard models assessed all-cause mortality in relation to procedural-induced abortion and provider-initiated preterm delivery, adjusting for cancer site, stage at diagnosis and age. Meta-analysis pooled the results across both provinces.</p><p><strong>Main outcome measures: </strong>All cause mortality.</p><p><strong>Results: </strong>There were 512 pregnant people diagnosed with cancer at <20 weeks' gestation and 782 diagnosed with cancer at <37 weeks' gestation. Neither procedural-induced abortion (adjusted hazard ratio [aHR] = 1.39, 95% CI: 0.32-6.17) nor provider-initiated preterm delivery (aHR = 1.17, 95% CI: 0.76-1.81) were associated with improved survival following adjustment for age, stage at diagnosis and cancer site.</p><p><strong>Conclusions: </strong>Neither procedural-induced abortion nor provider-initiated preterm birth was associated with improved survival in pregnant people diagnosed with cancer; however, these obstetric interventions are highly personal decisions best decided by the pregnant person in consultation with their care providers.</p>\",\"PeriodicalId\":50729,\"journal\":{\"name\":\"Bjog-An International Journal of Obstetrics and Gynaecology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2024-08-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bjog-An International Journal of Obstetrics and Gynaecology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/1471-0528.17937\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bjog-An International Journal of Obstetrics and Gynaecology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/1471-0528.17937","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的评估程序性流产或提供者引发的早产是否与癌症孕妇生存率的提高有关:设计:基于人群的回顾性队列研究:背景:加拿大艾伯塔省和安大略省,2003-2016年:方法:Cox 比例危险模型评估妊娠期癌症患者的生存率:Cox比例危险模型评估了与程序性流产和提供者引发的早产有关的全因死亡率,并对癌症部位、诊断分期和年龄进行了调整。Meta 分析汇总了两个省份的结果:主要结果测量:全因死亡率:结论:共有 512 名孕妇确诊患有癌症:程序性人工流产和医疗服务提供者引发的早产都与确诊癌症孕妇生存率的提高无关;然而,这些产科干预措施是高度个人化的决定,最好由孕妇与医疗服务提供者协商决定。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Procedural abortion, provider-initiated preterm delivery and survival in pregnant people with cancer: A population-based cohort study.

Objective: To assess whether procedural-induced abortion or provider-initiated preterm delivery are associated with improved survival in pregnant people with cancer.

Design: Retrospective population-based cohort study.

Setting: Provinces of Alberta and Ontario, Canada, 2003-2016.

Population: Females aged 18-50 years diagnosed with cancer at <20 weeks' (for the assessment of procedural-induced abortion) or <37 weeks' gestation (for the assessment of provider-initiated delivery).

Methods: Cox proportional hazard models assessed all-cause mortality in relation to procedural-induced abortion and provider-initiated preterm delivery, adjusting for cancer site, stage at diagnosis and age. Meta-analysis pooled the results across both provinces.

Main outcome measures: All cause mortality.

Results: There were 512 pregnant people diagnosed with cancer at <20 weeks' gestation and 782 diagnosed with cancer at <37 weeks' gestation. Neither procedural-induced abortion (adjusted hazard ratio [aHR] = 1.39, 95% CI: 0.32-6.17) nor provider-initiated preterm delivery (aHR = 1.17, 95% CI: 0.76-1.81) were associated with improved survival following adjustment for age, stage at diagnosis and cancer site.

Conclusions: Neither procedural-induced abortion nor provider-initiated preterm birth was associated with improved survival in pregnant people diagnosed with cancer; however, these obstetric interventions are highly personal decisions best decided by the pregnant person in consultation with their care providers.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
10.90
自引率
5.20%
发文量
345
审稿时长
3-6 weeks
期刊介绍: BJOG is an editorially independent publication owned by the Royal College of Obstetricians and Gynaecologists (RCOG). The Journal publishes original, peer-reviewed work in all areas of obstetrics and gynaecology, including contraception, urogynaecology, fertility, oncology and clinical practice. Its aim is to publish the highest quality medical research in women''s health, worldwide.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信